We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of invasive fungal diseases.
Mankind Pharma has launched Posaconazole Gastro-Resistant tablets with the brand name POSAFORCE 100. Posaconazole gastro-resistant tablets are indicated for treating mucormycosis patients.